Indegene share price

Balanced risk
  • 44%Low risk
  • 44%Moderate risk
  • 44%Balanced risk
  • 44%High risk
  • 44%Extreme risk
  • 599.00(0.08%)
    June 13, 2025 15:29:53 PM IST
    • NSE
    • BSE
  • Vol : 3.21M (NSE + BSE)
    Last 20 day avg : 3.21 M

Indegene is trading 0.08% upper at Rs 599.00 as compared to its last closing price. Indegene has been trading in the price range of 610.00 & 584.00. Indegene has given -0.74% in this year & 3.03% in the last 5 days. Indegene has TTM P/E ratio 34.00 as compared to the sector P/E of 71.72.There are 4 analysts who have initiated coverage on Indegene. There are 1 analysts who have given it a strong buy rating & 0.00 analysts have given it a buy rating. 0.00 analysts have given the stock a sell rating.The company posted a net profit of 117.60 Crores in its last quarter.Listed peers of Indegene include Delhivery (0.36%), Bls International Services (-0.03%), Indegene (0.08%).The Mutual Fund holding in Indegene was at 2.65% in 31 Mar 2025. The MF holding has increased from the last quarter. The FII holding in Indegene was at 5.24% in 31 Mar 2025. The FII holding has increased from the last quarter.

  • Overview
  • Financials
  • Forecast
  • Technical Analysis
  • Peers
  • Shareholding
  • About the company
  • FAQ

Overview

  • 1 D
  • 5 D
  • 1 M
  • 3 M
  • 6 M
  • 1 Y
  • 5 Y
  • MAX
Key Metrics

Updated on Jun 14, 2025, 01:54 PM UTC

  • Dividend Yield
    Annual dividends as a percentage of the stock price.
    0.33
    Lower than industry
  • P/B
    The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
    5.49
  • P/E
    Price-to-earnings ratio based on trailing 12-month earnings
    35.30
    Higher than historical values
  • Debt To Equity
    The debt-to-equity ratio, indicating a company's financial leverage.
    0.04
    Lower than industry
  • Beta
    Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
    -
  • PEG Ratio
    The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
    -
Price range
Day Range
Lowest
584.00
Highest
610.00
52 week range
Lowest
485.15
Highest
736.60
Indegene Financials
Financials
Financials include key reports like the Profit & Loss Statement (P&L), Balance Sheet, and Cash Flow Statement, providing insights into a company's performance, financial health, and liquidity
View all
  • Income
  • Balance Sheet
  • Cash Flow
Loading...
Units in the chart are in crores
Insights
  • Financial
  • Valuation
    • financial-insightsCompany is profitable
    • financial-insightsThe company has grown its March quarter profit by 24.05% from Rs 94.80 crore to Rs 117.60 crore, year-on-year
    • financial-insightsThe debt to equity of the company is lower than the industry median
    • financial-insightsCompany can comfortably pay off its interest obligations with its earnings
Indegene Technical Analysis
Pivot Level - classic
Info
Key price levels (support and resistance) calculated using the previous day's high, low, and close, aiding in technical analysis and trading decisions
  • R1
  • 628.83
  • R2
  • 657.92
  • R3
  • 683.73
Pivot603.02
  • S1
  • 573.93
  • S2
  • 548.12
  • S3
  • 519.03
Short Term
Info
Considers price movement over the last 1-2 weeks
Not Available
Long Term
Info
Considers price movement over the last 6 months
Not Available
  • Very Bearish
  • Bearish
  • Neutral
  • Very Bullish
  • Bullish
Trends unavailable at the moment.
Indegene Peers
Return Comparison
Peers Comparison
Names
Technical ratingPrice%ChangeMarket CapP/EP/BDividend YieldDebt to Equity
Delhivery
Bullish
359.150.3626,788.55167.102.83-12.09
Bls International Services
Bearish
370.05-0.0315,236.4730.038.810.2716.43
Indegene
Moderately Bullish
599.000.0814,380.0735.995.490.332.77
Rites
Bullish
290.650.4813,968.7436.135.272.560.25
Icra
Bullish
6,746.001.326,499.1537.706.080.900.78
Indegene Shareholding
View All
Shareholding Pattern
Breakdown of a company's ownership structure, showing stakes held by Promoters, Mutual Funds, FII(s) & Others.
    No Data
    Shareholding pattern for Indegene is currently unavailable
    Please check back later.
    Shareholding Insights
    • InsightsFIIs are invested in this company
    • InsightsFIIs holding has increased by 0.21 percentage points from previous quarter
    • InsightsMutual Funds holding has increased by 1.01 percentage points from previous quarter
    Mutual Fund Ownership
    View all
    Motilal Oswal Digital India Fund Regular Growth
    NA
    • Amount Invested (Cr.) 26.15
    • % of AUM 3.29
    Motilal Oswal Nifty Smallcap 250 Index Fund Regular Growth
    NA
    • Amount Invested (Cr.) 2.72
    • % of AUM 0.30
    Motilal Oswal Nifty 500 Fund Regular Growth
    NA
    • Amount Invested (Cr.) 0.71
    • % of AUM 0.03
    Indegene Corporate Actions
    View all
    • Board Meetings
    • AGM
    • Dividends
    • Bonus
    • Split
    • Rights
    Meeting DatePurpose
    2025-04-28Audited Results & Final Dividend
    2025-01-30Quarterly Results & Others
    2024-10-28Quarterly Results
    2024-08-01Quarterly Results
    2024-05-29Audited Results
    About the company Indegene
    • IndustryBusiness Services
    • ISININE065X01017
    • BSE Code544172
    • NSE CodeINDGN
    Indegene Limited is a life sciences commercialization company. It provides digital-led commercialization services for the life sciences industry, including biopharmaceutical, emerging biotech, and medical devices companies. The Company operates through four segments: Enterprise Medical Solutions, Enterprise Commercial Solutions, Omnichannel Activation, and Others. Its Enterprise Commercial Solutions segment primarily involves assisting life sciences companies with their digital marketing operations. Its Omnichannel Activation solutions segment helps life sciences companies leverage a digital first approach for optimizing the last-mile promotion of biopharmaceutical products and medical devices to healthcare professionals across multiple channels. Under its Enterprise Medical Solutions segment, it establishes centers of excellence to consolidate large scale regulatory and medical operations for its clients. Others segment offers enterprise clinical solutions and consultancy services.
    • Management Info
    • Manish GuptaExecutive Chairman of the Board, Chief Executive Officer
    • Suhas PrabhuChief Financial Officer
    • Sanjay ParikhExecutive Vice President, Executive Director
    • Anand NijegalExecutive Vice President - Global Operations
    • Viveksheel GhaiExecutive Vice President - Enterprise Commercial Solutions of Indegene, Inc.
    • Gaurav KapoorExecutive Vice President of Indegene, Inc.
    • Sameer LalSenior Vice President - Business Development of Indegene, Inc.
    • Rajesh NairNon-Executive Director, President of Indegene, Inc.
    Indegene Share Price FAQs

    Indegene is trading at 599.00 as on Fri Jun 13 2025 09:59:53. This is 0.08% upper as compared to its previous closing price of 598.55.

    The market capitalization of Indegene is 14380.07 Cr as on Fri Jun 13 2025 09:59:53.

    The average broker rating on Indegene is Hold. The breakup of analyst rating is given below -

    • 1 analysts have given a strong buy rating
    • 0.00 analysts have given a buy rating
    • 2 analysts have given a hold rating
    • 0.00 analysts have given a sell rating
    • 1 analysts have given a strong sell rating

    The 52 wk high for Indegene is 736.60 whereas the 52 wk low is 485.15

    Indegene can be analyzed on the following key metrics -

    • TTM P/E: 34.00
    • Sector P/E: 71.72
    • Dividend Yield: 0.33%
    • D/E ratio: 0.04

    Indegene reported a net profit of 406.70 Cr in 2025.

    The Mutual Fund Shareholding was 2.65% at the end of 31 Mar 2025.